BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26786311)

  • 1. Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women.
    Christen WG; Glynn RJ; Chew EY; Albert CM; Manson JE
    Ophthalmic Epidemiol; 2016; 23(1):32-9. PubMed ID: 26786311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial.
    Zhang SM; Cook NR; Albert CM; Gaziano JM; Buring JE; Manson JE
    JAMA; 2008 Nov; 300(17):2012-21. PubMed ID: 18984888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
    Lan X; Dang SN; Zhao YL; Yan H; Yan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Combination Folic Acid, Vitamin B
    Stone KL; Lui LY; Christen WG; Troen AM; Bauer DC; Kado D; Schambach C; Cummings SR; Manson JE
    J Bone Miner Res; 2017 Dec; 32(12):2331-2338. PubMed ID: 29244251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.
    Kang JH; Cook N; Manson J; Buring JE; Albert CM; Grodstein F
    Am J Clin Nutr; 2008 Dec; 88(6):1602-10. PubMed ID: 19064521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
    Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
    J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
    Lonn E; Held C; Arnold JM; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
    Can J Cardiol; 2006 Jan; 22(1):47-53. PubMed ID: 16450017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials.
    Dong H; Pi F; Ding Z; Chen W; Pang S; Dong W; Zhang Q
    PLoS One; 2015; 10(9):e0137533. PubMed ID: 26355679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
    Christen WG; Glynn RJ; Chew EY; Albert CM; Manson JE
    Arch Intern Med; 2009 Feb; 169(4):335-41. PubMed ID: 19237716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Combined Treatment With Folic Acid, Vitamin B
    Christen WG; Cook NR; Van Denburgh M; Zaharris E; Albert CM; Manson JE
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.
    Song Y; Cook NR; Albert CM; Van Denburgh M; Manson JE
    Diabetes; 2009 Aug; 58(8):1921-8. PubMed ID: 19491213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
    Saposnik G; Ray JG; Sheridan P; McQueen M; Lonn E;
    Stroke; 2009 Apr; 40(4):1365-72. PubMed ID: 19228852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E and age-related cataract in a randomized trial of women.
    Christen WG; Glynn RJ; Chew EY; Buring JE
    Ophthalmology; 2008 May; 115(5):822-829.e1. PubMed ID: 18067963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of folic acid and vitamin-B12 supplementation on fracture risk and cardiovascular disease: Extended follow-up of the B-PROOF trial.
    Oliai Araghi S; Kiefte-de Jong JC; van Dijk SC; Swart KMA; Ploegmakers KJ; Zillikens MC; van Schoor NM; de Groot LCPGM; Lips P; Stricker BH; Uitterlinden AG; van der Velde N
    Clin Nutr; 2021 Mar; 40(3):1199-1206. PubMed ID: 32800386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.
    Christen WG; Glynn RJ; Gaziano JM; Darke AK; Crowley JJ; Goodman PJ; Lippman SM; Lad TE; Bearden JD; Goodman GE; Minasian LM; Thompson IM; Blanke CD; Klein EA
    JAMA Ophthalmol; 2015 Jan; 133(1):17-24. PubMed ID: 25232809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related cataract in a randomized trial of vitamins E and C in men.
    Christen WG; Glynn RJ; Sesso HD; Kurth T; MacFadyen J; Bubes V; Buring JE; Manson JE; Gaziano JM
    Arch Ophthalmol; 2010 Nov; 128(11):1397-405. PubMed ID: 21060040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.